Neovascularization at tendon–bone junction

Neovascularization at the tendon–bone junction refers to the formation of new blood vessels within the region where a tendon attaches to bone, also known as the enthesis. This process is a physiological response during tissue repair following injury or degenerative changes. It plays a dual role—facilitating nutrient delivery and cellular infiltration necessary for healing, but excessive or aberrant neovascularization is implicated in chronic pain syndromes such as tendinopathy[3][5][8]. At the microscopic level, neovessels are observed after interventions like low-energy shock wave therapy and are associated with increased numbers of capillaries and muscularized vessels within weeks post-treatment[1]. The presence of these new vessels can be quantified using imaging modalities such as Doppler ultrasonography, which provides a "neovascularization score" that correlates with clinical outcomes after therapies like ESWT for insertional Achilles tendinopathy[7]. Therapeutically, strategies either aim to promote neovascularization (to enhance healing) or inhibit it (to reduce pain), depending on clinical context. For example, platelet-rich plasma injections may stimulate angiogenesis for regenerative purposes while sclerosing agents target abnormal neovessels to alleviate symptoms in chronic cases[8]. Importantly, "neovascularization at tendon–bone junctions" is not itself a molecular target such as an enzyme or receptor; rather it describes a biological process involving multiple cell types and signaling pathways—including VEGF-mediated angiogenic signaling—at an anatomical site. Therefore, this entry should not be considered a canonical therapeutic target but rather an important pathological/physiological phenomenon relevant to musculoskeletal medicine. If you require structured information about specific molecular targets involved in this process—such as Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)—please specify further so that precise molecular data can be provided.

Other names

Neovascularization at enthesisAngiogenesis at tendon–bone interfaceNeoangiogenesis in tendon insertion healing

Promotion or inhibition of new blood vessel growth to modulate healing and pain[8]